|
2025 Conference Publication Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferationDousset, L., Zhou, C., Kao, Y., Tan, S., Muller, N., Sormani, L., Cox, C., Soyer, H.P., Stark, M.S., Wong, H., Roy, E. and Khosrotehrani, K. (2025). Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferation. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.777 |
|
2024 Conference Publication Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in MelanomaSormani, L., Hashemi, G., Li, H., Zhou, C., Li, K., Chan, S., Tan, S.X., Nguyen, Q., Roy, E. and Khosrotehrani, K. (2024). Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in Melanoma. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.391 |
|
2023 Conference Publication Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasisHashemi, G., Le Bourhis, L. Sormani, Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.jid.2023.03.1288 |
